Tribunal upholds CIT(A) on expenditure disallowance under Indian Medical Council Regs, reduces deduction under section 80IC

The Tribunal upheld the CIT(A)'s decision to allow expenditure disallowance under Indian Medical Council Regulations, reducing deduction under section 80IC due to apportioning R&D expenses. The Tribunal partially allowed the Revenue's appeal on the reopening of assessment for R&D expenses allocation, remanding the matter to the CIT(A) for further examination.

---

---

Issues Involved:
1. Disallowance of expenditure under Indian Medical Council Regulations.
2. Reduction of deduction under section 80IC due to apportioning of R&D expenses.
3. Reopening of assessment for allocation of R&D expenses.

Analysis:

Issue 1: Disallowance of Expenditure under Indian Medical Council Regulations
The Revenue appealed against the deletion of disallowance of expenditure amounting to INR 2,99,27,462 under Indian Medical Council (Professional conduct, Etiquette and Ethics) Regulations, 2002. The CIT(A) allowed the claim based on the Tribunal's decision in the assessee's own case for AY 2011-12 and 2012-13. The Tribunal held that the CBDT circular, which the AO relied on, was not applicable for the relevant assessment year. The Mumbai ITAT decision in the case of Syncom Formulations (I) Ltd was also followed, stating that the circular did not warrant any disallowance. The Tribunal upheld the CIT(A)'s decision, allowing the expenditure and dismissing the Revenue's appeal.

Issue 2: Reduction of Deduction under Section 80IC due to Apportioning of R&D Expenses
The Revenue challenged the CIT(A)'s decision to allow the assessee's claim for deduction under section 80IC by apportioning R&D expenses among various units. The AO disallowed the apportionment and reduced the deduction under section 80IC. The CIT(A) upheld the assessee's claim, citing that R&D activities were not carried out at all manufacturing units but at independent R&D units. The AO's decision to exclude trading sales before apportioning R&D expenses was disputed. The Tribunal found no fault in the CIT(A)'s order, following the decision of the Co-ordinate Bench and upholding the allowance of the deduction under section 80IC.

Issue 3: Reopening of Assessment for Allocation of R&D Expenses
The AO reopened the assessment to allocate R&D expenses based on turnover, excluding trading sales. The CIT(A) deleted the allocation made during the original assessment, but the AO reiterated the allocation in the reopening. The Revenue appealed, arguing that the AO's reassessment was not permissible as the issue was already subject to appeal. The Tribunal noted that while the AO excluded trading sales in the reassessment, the CIT(A) did not decide the issue on merit. Considering the legal provisions and precedents, the Tribunal remanded the matter to the CIT(A) for a detailed examination and decision on the allocation of R&D expenses.

In conclusion, the Tribunal partially allowed the Revenue's appeal and dismissed the assessee's cross objection, emphasizing the need for a thorough review of the allocation of R&D expenses by the CIT(A) based on merit.

---